Key points
- NAD+ is an essential coenzyme involved in cellular energy production, redox balance, and certain repair processes.
- It is extensively researched in the fields of aging biology, metabolism, and recovery; human data regarding IV administration are still evolving.
- Infusion rate can significantly affect tolerance; individualized dosing and administration duration are important.
What is IV NAD+ Administration?
Nicotinamide adenine dinucleotide (NAD+) plays a role in numerous cellular systems, including glycolysis, the citric acid cycle, the electron transport chain, and sirtuins/PARPs. Alterations in NAD metabolism in certain tissues with age are among the key topics of longevity research.
Who can it be considered for?
IV NAD+ may be considered under physician supervision in selected individuals with goals regarding energy metabolism, recovery, or healthy aging, with existing human data and uncertainties clearly discussed. An individual’s suitability for the procedure is determined based on medical history, metabolic status, current medications, and the measurability of goals.
What does the research say?
Human studies investigate the metabolic responses, safety, tolerability, and pharmacokinetics of NAD+ infusions. Because a significant portion of current studies have small sample sizes or short durations, the magnitude of the long-term clinical effect on energy, function, disease risk, and healthy aging has not yet been fully clarified. Nonetheless, the role of NAD metabolism in aging biology continues to be a robust area of research.
Pre-procedure evaluation
- Medical history, current medications, and personal goals
- Kidney and liver functions
- Metabolic status, glucose, and cardiovascular risks
- Oral NAD precursors, vitamins, and other supplements
- Other causes of fatigue or decreased performance
Administration and monitoring
NAD+ infusions are generally administered slowly according to individual tolerance. When the infusion rate increases, chest tightness, nausea, abdominal cramps, or restlessness may occur. For this reason, the rate, duration, and dose are adjusted based on clinical response; if discomfort develops, the administration can be slowed or discontinued.
Safety and considerations
Short-term human data provide information regarding feasibility and tolerability under specific protocols. Long-term safety data are still expanding. Conditions such as pregnancy, active cancer treatment, severe organ disease, or complex medication regimens require an individualized evaluation.
Our approach at our Bodrum clinic
We approach NAD+ administration not merely as an isolated “anti-aging drip,” but rather as a potential component of a broader longevity and metabolic evaluation plan. First, sleep, exercise capacity, body composition, metabolic risks, nutrition, and, when necessary, biological age markers are evaluated. If there is suitability for IV NAD+, the procedural goals and follow-up metrics are determined on an individualized basis.
Frequently asked questions
How is NAD+ evaluated within a healthy aging plan?
NAD metabolism is an important area of research in the biology of aging. Because human data regarding IV administration are still evolving, the most appropriate approach is not to present NAD+ with standalone rejuvenation claims, but to evaluate it alongside the individual’s overall health, metabolism, and functional markers.
Why is the infusion administered slowly?
Rapid infusion can increase nausea, chest tightness, abdominal cramps, or feelings of restlessness in some individuals. Therefore, the rate is adjusted according to individual tolerance.
Are NAD+, NR, and NMN the same thing?
No; although NAD+, NR, and NMN are related to the same metabolic pathway, they are distinct molecules with different pharmacokinetic properties. The scope of human studies also varies depending on the product and route of administration.
How are energy and recovery monitored?
Sleep, daily function, exercise tolerance, and fatigue complaints can be recorded at baseline and monitored serially. In this way, individual change is evaluated not solely through subjective perception, but through measurable parameters whenever possible.
Related content
- Healthy Aging and Longevity
- IV and Infusion Therapies
- Biological Age, PhenoAge, and Epigenetic Clocks
- Mitochondrial Support IV Applications
References
- Elhassan YS et al. Studies on NAD+ metabolism and human aging.
- Recent pilot studies examining the metabolic response and tolerability of IV NAD+ and NR administrations.
Written and medically reviewed by: Dr. Kerem Çağlayan
Last medical review: September 10, 2026
Disclaimer: This content is for general medical information purposes only. It does not replace an individualized diagnosis or treatment plan.
